Ionis Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $372.3M | $242.1M | $399.3M | $276.5M | $869.2M | $397.7M | $683.3M | $278.8M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | $10.0M | $12.5M | $7.4M | $22.0M | $24.8M | $22.0M | $18.2M | $8.6M |
| Total Current Assets | $2.99B | $2.62B | $2.64B | $2.20B | $2.35B | $2.13B | $2.72B | $2.21B |
| Property, Plant & Equipment | $123.0M | $94.3M | $71.0M | $74.3M | $178.1M | $181.1M | $153.7M | $132.2M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | $29.0M | $27.9M | $25.7M | $24.0M |
| Total Assets | $3.52B | $3.00B | $2.99B | $2.53B | $2.61B | $2.39B | $3.23B | $2.67B |
| Liabilities | ||||||||
| Accounts Payable | $28.1M | $43.0M | $26.0M | $17.9M | $11.9M | $17.2M | $16.1M | $28.7M |
| Total Current Liabilities | $781.6M | $309.3M | $448.1M | $311.6M | $240.6M | $598.9M | $273.0M | $280.3M |
| Long-Term Debt | $1.33B | $1.20B | $1.24B | $1.18B | — | $539.1M | $785.5M | — |
| Total Liabilities | $3.03B | $2.42B | $2.60B | $1.96B | $1.84B | $1.65B | $1.55B | $1.48B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-2.63B | $-2.25B | $-1.80B | $-1.43B | $-1.16B | $-1.13B | $-707.5M | $-967.3M |
| Total Stockholders' Equity | $489.1M | $588.4M | $386.7M | $572.9M | $771.7M | $743.3M | $1.47B | $1.05B |